{
  "success": true,
  "pagesUsed": [
    3,
    9,
    11,
    12,
    13,
    14,
    15,
    16,
    17,
    18,
    23,
    34,
    57
  ],
  "modelUsed": "gemini-2.5-pro",
  "confidence": 1.0,
  "scheduling": {
    "timings": [
      {
        "id": "timing_1",
        "name": "Screening Window",
        "type": {
          "id": "52efef31-dcd0-4d6f-af26-e6c105a46030",
          "code": "C71152",
          "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
          "codeSystemVersion": "25.01d",
          "decode": "Between",
          "instanceType": "Code"
        },
        "value": "P0D",
        "valueLabel": "Screening Window",
        "relativeToFrom": {
          "id": "5506b31e-2617-4b2b-a2a7-5acd116d5669",
          "code": "C71154",
          "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
          "codeSystemVersion": "25.01d",
          "decode": "Randomization",
          "instanceType": "Code"
        },
        "relativeFromScheduledInstanceId": "835699a2-fd3d-4e1e-ab7e-e4931481831b",
        "instanceType": "Timing",
        "windowLower": "-P28D",
        "windowUpper": "-P2D"
      },
      {
        "id": "timing_2",
        "name": "Washout Period",
        "type": {
          "id": "32a886f6-8c14-4d6f-8f16-4f7e1a9a6b8f",
          "code": "C71152",
          "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
          "codeSystemVersion": "25.01d",
          "decode": "Between",
          "instanceType": "Code"
        },
        "value": "P0D",
        "valueLabel": "Washout Period",
        "relativeToFrom": {
          "id": "5f4137d4-2bd4-4c1c-91e3-00f8bb636edd",
          "code": "C71157",
          "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
          "codeSystemVersion": "25.01d",
          "decode": "Previous Visit",
          "instanceType": "Code"
        },
        "relativeFromScheduledInstanceId": "ff5e2f75-b699-4b26-a7c2-c51ce835bd57",
        "instanceType": "Timing",
        "windowLower": "P3D",
        "windowUpper": "P14D"
      },
      {
        "id": "timing_3",
        "name": "Follow-up Visit Window",
        "type": {
          "id": "dc2a472d-4f7d-4a79-a8ec-878cdf3e2a54",
          "code": "C71148",
          "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
          "codeSystemVersion": "25.01d",
          "decode": "Fixed Reference",
          "instanceType": "Code"
        },
        "value": "P28D",
        "valueLabel": "Day 28",
        "relativeToFrom": {
          "id": "e27253c7-ad6a-4221-a765-4facabf68255",
          "code": "C71156",
          "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
          "codeSystemVersion": "25.01d",
          "decode": "Last Dose",
          "instanceType": "Code"
        },
        "relativeFromScheduledInstanceId": "fc420b03-75cf-4fb0-85d2-8e1a8729e62e",
        "instanceType": "Timing",
        "windowLower": "-P2D",
        "windowUpper": "P2D"
      },
      {
        "id": "timing_4",
        "name": "Discharge from CRU",
        "type": {
          "id": "24d1402c-55b2-49a1-8091-f9522b6a24c9",
          "code": "C71150",
          "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
          "codeSystemVersion": "25.01d",
          "decode": "After",
          "instanceType": "Code"
        },
        "value": "PT6H",
        "valueLabel": "6 hours",
        "relativeToFrom": {
          "id": "208d583b-77ca-4de5-8efe-6cc8e8b0e86a",
          "code": "C71156",
          "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
          "codeSystemVersion": "25.01d",
          "decode": "Last Dose",
          "instanceType": "Code"
        },
        "relativeFromScheduledInstanceId": "6eaf9151-3b29-4885-8756-d42c4343caca",
        "instanceType": "Timing",
        "windowLower": "PT0H",
        "windowUpper": "P0D"
      },
      {
        "id": "timing_5",
        "name": "Study Drug Administration Timing",
        "type": {
          "id": "4e7fcb98-f148-4c0a-bbf9-85d08e3f12e4",
          "code": "C71150",
          "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
          "codeSystemVersion": "25.01d",
          "decode": "After",
          "instanceType": "Code"
        },
        "value": "PT5M",
        "valueLabel": "5 minutes",
        "relativeToFrom": {
          "id": "0775b962-8dcc-4644-a5d5-39870e9cfdeb",
          "code": "C71153",
          "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
          "codeSystemVersion": "25.01d",
          "decode": "Study Start",
          "instanceType": "Code"
        },
        "relativeFromScheduledInstanceId": "a3f7b8ca-c54f-4d1f-9261-1d24b9af2988",
        "instanceType": "Timing",
        "windowLower": "P0D",
        "windowUpper": "P0D"
      },
      {
        "id": "timing_6",
        "name": "Additional Follow-up Immunogenicity Sampling",
        "type": {
          "id": "89b7e50c-dfc9-4dfd-938b-985e92554415",
          "code": "C71148",
          "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
          "codeSystemVersion": "25.01d",
          "decode": "Fixed Reference",
          "instanceType": "Code"
        },
        "value": "P12W",
        "valueLabel": "12 weeks",
        "relativeToFrom": {
          "id": "093d8cea-d2f4-45e2-939e-530630b8d3fe",
          "code": "C71157",
          "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
          "codeSystemVersion": "25.01d",
          "decode": "Previous Visit",
          "instanceType": "Code"
        },
        "relativeFromScheduledInstanceId": "eb4c5d7b-3da9-4ce8-b4fd-73c228ee1fc8",
        "instanceType": "Timing",
        "windowLower": "-P7W",
        "windowUpper": "P7W"
      }
    ],
    "conditions": [
      {
        "id": "cond_1",
        "name": "Admission Rescheduling Condition",
        "instanceType": "Condition",
        "description": "Condition for rescheduling admission to CRU on Day 1.",
        "text": "Plasma Glucose (PG) level is not 90 to 250 mg/dL on Day 1."
      },
      {
        "id": "cond_2",
        "name": "Insulin Infusion Stop Condition",
        "instanceType": "Condition",
        "description": "Condition to stop the insulin infusion used to induce hypoglycemia.",
        "text": "Bedside Plasma Glucose (PG) is <60 mg/dL."
      },
      {
        "id": "cond_3",
        "name": "Fasting Requirement",
        "instanceType": "Condition",
        "description": "Fasting requirement for sample collection in Periods 1 and 2.",
        "text": "At Periods 1 and 2, samples should be collected from patients who have fasted at least 8 hours before any study procedures."
      },
      {
        "id": "cond_4",
        "name": "Interim Safety Review Trigger",
        "instanceType": "Condition",
        "description": "Condition triggering an interim safety review to decide on study continuation.",
        "text": "Safety data will be reviewed after the first 6 patients (regardless of type of diabetes) are administered LY900018 in Period 2."
      },
      {
        "id": "cond_5",
        "name": "TE ADA Positive",
        "instanceType": "Condition",
        "description": "Condition for entering additional follow-up.",
        "text": "Patients with treatment-emergent antidrug antibodies (TE ADA) at follow-up/ED will undergo additional follow-up."
      },
      {
        "id": "cond_6",
        "name": "Patient Replacement Criteria",
        "instanceType": "Condition",
        "description": "Condition for replacing a discontinued patient.",
        "text": "If patients discontinue from the study before completion of both periods with evaluable primary outcome for any reason, the patient may be replaced. Replacement should not occur beyond 75 patients enrolled."
      }
    ],
    "conditionAssignments": [],
    "transitionRules": [
      {
        "id": "trans_1",
        "name": "Transition to Additional Follow-up",
        "instanceType": "TransitionRule",
        "transitionType": "Epoch Transition",
        "fromElementId": "epoch_followup",
        "toElementId": "epoch_additional_followup",
        "text": "Patients with TE ADA at follow-up/ED will undergo additional follow-up."
      },
      {
        "id": "trans_2",
        "name": "Procedures on Premature Discontinuation",
        "instanceType": "TransitionRule",
        "transitionType": "Discontinuation",
        "text": "Patients discontinuing from the study prematurely for any reason must complete AE and follow-up procedures as shown in the Schedule of Activities."
      },
      {
        "id": "trans_3",
        "name": "Handling of Inadvertently Enrolled Patients",
        "instanceType": "TransitionRule",
        "transitionType": "Discontinuation",
        "text": "If a patient who did not meet enrollment criteria was inadvertently enrolled, a discussion must occur between the Lilly CP/CRP and the investigator to determine if the patient may continue in the study."
      }
    ],
    "scheduleTimelineExits": [
      {
        "id": "exit_1",
        "name": "Study Completion",
        "exitType": "Completion",
        "instanceType": "ScheduleTimelineExit",
        "description": "Completion of all protocol-required visits, including the final follow-up visit."
      },
      {
        "id": "exit_2",
        "name": "Completion of Additional Follow-up",
        "exitType": "Completion",
        "instanceType": "ScheduleTimelineExit",
        "description": "Additional follow-up for TE ADA completes when the titer returns to baseline or until 1 year after the last dose of study treatment."
      },
      {
        "id": "exit_3",
        "name": "Discontinuation due to Other Study",
        "exitType": "Early Termination",
        "instanceType": "ScheduleTimelineExit",
        "description": "Patient is discontinued for enrollment in any other clinical study involving an investigational product or judged not to be scientifically or medically compatible with this study."
      },
      {
        "id": "exit_4",
        "name": "Discontinuation for Medical/Safety/Regulatory Reasons",
        "exitType": "Early Termination",
        "instanceType": "ScheduleTimelineExit",
        "description": "Patient is discontinued if participation needs to be stopped for medical, safety, regulatory, or other reasons consistent with applicable laws, regulations, and good clinical practice."
      },
      {
        "id": "exit_5",
        "name": "Discontinuation by Investigator Decision",
        "exitType": "Early Termination",
        "instanceType": "ScheduleTimelineExit",
        "description": "The investigator decides that the patient should be discontinued from the study for any reason."
      },
      {
        "id": "exit_6",
        "name": "Withdrawal of Consent",
        "exitType": "Early Termination",
        "instanceType": "ScheduleTimelineExit",
        "description": "The patient, or legal representative, requests to be withdrawn from the study."
      },
      {
        "id": "exit_7",
        "name": "Study Termination for Safety",
        "exitType": "Early Termination",
        "instanceType": "ScheduleTimelineExit",
        "description": "The entire study will be stopped if deemed necessary for patient safety following the review of data from the first 6 patients to complete Period 2 Day 1."
      },
      {
        "id": "exit_8",
        "name": "Lost to Follow-up",
        "exitType": "Early Termination",
        "instanceType": "ScheduleTimelineExit",
        "description": "A patient will be considered lost to follow-up if he or she repeatedly fails to return for scheduled visits and is unable to be contacted by the study site."
      }
    ],
    "scheduledDecisionInstances": [
      {
        "id": "dec_1",
        "name": "Interim Safety Review Decision",
        "timepointId": "After first 6 patients complete Period 2",
        "instanceType": "ScheduledDecisionInstance",
        "description": "Decision point to continue dosing remaining patients or stop the study based on safety review of the first 6 patients. If no clinically significant safety findings are noted, the remaining patients will be dosed.",
        "conditionIds": [
          "cond_4"
        ]
      },
      {
        "id": "dec_2",
        "name": "Inadvertent Enrollment Decision",
        "timepointId": "Upon Discovery",
        "instanceType": "ScheduledDecisionInstance",
        "description": "Decision point for inadvertently enrolled patients to determine if they may continue in the study, requiring documented approval from the sponsor."
      }
    ],
    "summary": {
      "timingCount": 6,
      "conditionCount": 6,
      "transitionRuleCount": 3,
      "exitCount": 8
    }
  }
}